A Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies

Clinical trial NCT04172597 · TERMINATED

Trial details

NCT number: NCT04172597
Sponsor: Spectrum Pharmaceuticals, Inc
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Colorectal Cancer Solid Tumor Glioblastome Multiforme

Start date: 2019-12-23
Primary completion: 2022-03-29
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.